🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomised, double-blind, placebo-controlled, parallel-group tria...
Status
Completed
Location
Kristavita, JSC
Start Date
2019-02-25
Trial ID
NCT05353686
NorMIGS is a non-randomized clinical study of intraocular pressure lowering...
Status
Recruiting
Location
Department of Ophthalmology, Oslo University Hospital
Start Date
2022-04-22
Trial ID
NCT05340647
Treatments Being Tested
This is a single-dose dose escalation trial in a randomised, single-blind, ...
Status
Completed
Location
Odense University Hospital
Start Date
2017-09-18
Trial ID
NCT03278158
The objective of this study is to evaluate the efficacy and safety of glauc...
Status
Unknown
Location
Multiple Locations
Start Date
2023-05-31
Trial ID
NCT05892185
This methodological research is aimed to examine the effectiveness of the m...
Status
Withdrawn
Location
Adnan Menderes University
Start Date
2022-09-01
Trial ID
NCT05557396
Treatments Being Tested
XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: ...
Status
Completed
Location
Military Institute of Medicine - National Research Institute
Start Date
2014-12-02
Trial ID
NCT07350200
Treatments Being Tested
Multicentric evaluation of best corrected visual acuity of the XEN implant ...
Status
Recruiting
Location
Dept. Ophthalmology and Optometry Paracelsus Medical University
Start Date
2023-12-20
Trial ID
NCT05439161
Treatments Being Tested
Glaucoma is one of the leading causes of permanent blindness in the world. ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07143708
Treatments Being Tested
A retrospective, non-interventional, observational, multi-center, chart rev...
Status
Completed
Location
Clinical Trials Registry Team
Start Date
2019-04-05
Trial ID
NCT03868254
Treatments Being Tested